NCT06429943View on ClinicalTrials.gov

Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

October 15, 2022

Study Completion Date

January 10, 2023

Conditions
SAH (Subarachnoid Hemorrhage)
Trial Locations (1)

Unknown

Pomeranian Medical University, University Hospital no.1, Szczecin

All Listed Sponsors
lead

Pomeranian Medical University Szczecin

OTHER

NCT06429943 - Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study | Biotech Hunter | Biotech Hunter